Results 21 to 30 of about 27,813 (176)

Patient‐Reported Outcomes in a Multidisciplinary Electrophysiology‐Psychology Ventricular Arrhythmia Clinic

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background Ventricular arrhythmias (VAs) and their treatment have been associated with psychological distress and diminished quality of life (QOL).
Uday Sandhu, Andrew T. Nguyen, John Dornblaser, Andrew Gray, Karen Paladino, Charles A Henrikson, Adrienne H. Kovacs, Babak Nazer   +7 more
doaj   +1 more source

Coronary Flow in Hypertrophic Obstructive Cardiomyopathy—Immediate Effects of Alcohol Septal Ablation

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Hypertrophic cardiomyopathy is associated with alterations in coronary microvascular function which have variable pathophysiologic mechanisms, and variable reversibility acutely and chronically following alcohol septal ablation (ASA).
Vojko V. Misevic, Ana N. Golocevac, Kosta S. Krupnikovic, Stefan B. Timcic, Natalija B. Arnautovic, Dragana D. Radoicic, Milan R. Dobric, Aleksandar D. Mandic, Stefan S. Zivkovic, Aleksa D. Obradovic, Vladimir D. Mihajlovic, Natalija R. Odanovic, Ivan S. Ilic   +12 more
wiley   +1 more source

S-ICD oversensing detected by remote monitoring using a new atrial fibrillation diagnostic algorithm

Indian Pacing and Electrophysiology Journal, 2018
A 64-year-old male with a high body mass index, and subcutaneous implantable cardioverter defibrillator, (S-ICD) presented with a remote transmission of inappropriately diagnosed AF episodes, due to oversensing of P and T waves.
Christopher Monkhouse, Andre Jacinto, Pier D. Lambiase   +2 more
doaj   +1 more source

First Case Report of Electromagnetic Interference Between Percutaneous Ventricular Assist Device and Implantable Cardioverter-Defibrillator

JACC: Case Reports, 2023
Electromagnetic interference (EMI) between implantable left ventricular assist devices and cardiac implantable electronic devices has been observed. We demonstrated the first case of EMI between a percutaneous ventricular assist device and an implantable
Kosuke Takahari, MD, Takafumi Oka, MD, PhD, Takayuki Sekihara, MD, Kentaro Ozu, MD, Yasuhiro Akazawa, MD, PhD, Daisuke Nakamura, MD, Isamu Mizote, MD, PhD, Tomohito Ohtani, MD, PhD, Shungo Hikoso, MD, PhD, Yasushi Sakata, MD, PhD   +9 more
doaj   +1 more source

Comparison Between the Acurate Neo and the Acurate Neo 2 Transcatheter Heart Valve System: Impact of Midframe Under‐Expansion

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Transcatheter aortic valve implantation (TAVI) with the Acurate Neo has been linked to a significant incidence of paravalvular leakage (PVL), addressed by the Acurate Neo 2 incorporating an active sealing skirt. Recent findings suggest that midframe under‐expansion is associated with worse outcomes.
Lisa Crusius, Thaddäus Ast, Stephan Haussig, Jean‐Honoré Steul, Felix J. Woitek, Peter Sick, Tomas Madej, Utz Kappert, Axel Linke, Norman Mangner   +9 more
wiley   +1 more source

Subcutaneous Implantable Cardioverter Defibrillator: Early Experience

Brazilian Journal of Cardiovascular Surgery
Introduction: The implantable cardioverter defibrillator had been increasing the survival of patients at high risk for sudden cardiac death. The subcutaneous implantable cardioverter defibrillator was developed to mitigate the complications inherent to ...
Fernando Sérgio Oliva Souza, Vanessa Sepulvida Matos, Marcos Cesar Valério Almeida, Samuel Campagiotto Weiss, Lucas Henrique Borges Rodrigues, Pedro Augusto Gori Lima, Davi Bongiolo Mattos   +6 more
doaj   +1 more source

Diagnosis of atrial fibrillation in heart failure patients with implantable cardioverter defibrillator or cardiac resynchronisation therapy

Archives of Medical Science, 2021
Introduction Implantable cardioverter defibrillators register various types of arrhythmias. Thus they can be exploited to better identify patients with atrial fibrillation episodes and increase the proportion of patients who may benefit from ...
Barbara Dominik, Przemyslaw Mitkowski, Wojciech Zorawski, Ilona Kowalik, Adam Ciesielski   +4 more
doaj   +1 more source

Percutaneous Left Atrial Appendage Closure Using a PFO Occluder After an Incomplete Surgical Ligation

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT The case regards a 73‐year‐old male who was referred for consideration of percutaneous left atrial appendage closure. His left atrial appendage was ligated during prior mitral valve surgery, but was noted to be patent on a recent transesophageal echocardiography. An Amulet device was selected based on CT planning.
Zach Rozenbaum, Eric Gnall
wiley   +1 more source

Dental management of a patient fitted with subcutaneous Implantable Cardioverter Defibrillator device and concomitant warfarin treatment

Saudi Dental Journal, 2015
Automated Implantable Cardioverter Defibrillators (AICD), simply known as an Implantable Cardioverter Defibrillator (ICD), has been used in patients for more than 30 years.
Altaf Hussain Shah, Hesham Saleh Khalil, Mohammed Zaheer Kola   +2 more
doaj   +1 more source

Enhancing Evidence Generation by Linking Randomized Clinical Trials to Real‐World Data: The INVESTED‐Medicare Linkage Study

Clinical Pharmacology &Therapeutics, EarlyView.
Real‐world evidence (RWE) derived from real‐world data (RWD) can complement randomized controlled trials (RCTs), yet the validity of RWD relative to RCT data remains insufficiently characterized. We obtained post hoc consent and linked individual participant data from the US‐based INVESTED trial (2016–2019) with Medicare fee‐for‐service claims (2012 ...
Hanseul Cho, HoJin Shin, Mehdi Najafzadeh, Brian Claggett, Janinne Ortega‐Montiel, Jun Liu, Julie M. Paik, Narlina F. Lalani, Marie C. Bradley, John Concato, Scott D. Solomon, Orly Vardeny, Elisabetta Patorno   +12 more
wiley   +1 more source